(Q44404478)

2 December 2017

title

YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine (English)

1 reference

2 December 2017

Bozdayi AM

1

1 reference

2 December 2017

Uzunalimoğlu O

2

1 reference

2 December 2017

Türkyilmaz AR

3

1 reference

2 December 2017

Aslan N

4

1 reference

2 December 2017

Sezgin O

5

1 reference

2 December 2017

Sahin T

6

1 reference

2 December 2017

Bozdayi G

7

1 reference

2 December 2017

Cinar K

8

1 reference

2 December 2017

Pai SB

9

1 reference

2 December 2017

Pai R

10

1 reference

2 December 2017

Bozkaya H

11

1 reference

2 December 2017

Karayalçin S

12

1 reference

2 December 2017

Yurdaydin C

13

1 reference

2 December 2017

Schinazi RF

14

1 reference

2 December 2017

publication date

1 July 2003

1 reference

Journal of Viral Hepatitis

2 December 2017

published in

1 reference

2 December 2017

volume

10

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

256-265

1 reference

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00435.X

10.1046/J.1365-2893.2003.00435.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference